What is the best approach to treating schizophrenia in developing countries?
What is the best approach to treating schizophrenia in developing countries?
复制标题
DOI：
10.1371/journal.pmed.0040159
复制
发表时间：
2007-06
期刊：
影响因子：
15.8
通讯作者：
Thara R
中科院分区：
文献类型：
--
作者：
Patel V;Farooq S;Thara R
辩论背景：据估计，精神分裂症影响着中低收入国家的2500万人，平均终生风险约为1%。这种疾病与各种原因造成的死亡率过高有关。医学研究所2001年关于发展中国家精神疾病的报告发现，1990年，这些国家三分之二以上的精神分裂症患者没有接受任何治疗（http：//www.nap.edu/catalog/10111.html）。报告没有发现任何证据表明，自1990年以来，发展中国家接受治疗的人数比例有所增加。现在，低收入国家的精神卫生专业人员就如何最好地改善患者护理展开了辩论。在这篇文章中，三位精神科医生对发展中国家精神分裂症治疗工作的现状以及可以采取的措施提出了不同的观点，以增加接受治疗的患者比例。三位精神病学家对发展中国家精神分裂症治疗的现状发表了不同的观点。
Background to the debate: Schizophrenia affects an estimated 25 million people in low- and middle-income countries, with an average lifetime risk of about 1%. The illness is associated with excess mortality from a variety of causes. A 2001 Institute of Medicine report on mental illness in developing countries found that in 1990, over two-thirds of people with schizophrenia in these countries were not receiving any treatment (http://www.nap.edu/catalog/10111.html). The report found no evidence that the proportion of treated people in the developing world had increased since 1990. There is now a debate among mental health professionals in low-income countries over how best to improve patient care. In this article, three psychiatrists give their different viewpoints on the current status of treatment efforts for schizophrenia in the developing world and the measures that can be taken to increase the proportion of patients receiving treatment. Three psychiatrists give their different viewpoints on the current status of treatment efforts for schizophrenia in the developing world.